Literature DB >> 14678257

Immunopathogenic mechanisms in psoriasis.

J E Gudjonsson1, A Johnston, H Sigmundsdottir, H Valdimarsson.   

Abstract

Psoriasis is a common autoimmune skin disease characterized by T cell-mediated hyperproliferation of keratinocytes. The disease has a strong but complex genetic background with a concordance of approximately 60% in monozygotic twins, and recent linkage and high resolution association studies indicate that HLA-Cw*0602 is itself a major susceptibility allele for psoriasis. Patients carrying this allele have been shown to have different clinical features and earlier age of disease onset, and patients homozygous for this allele have about 2.5 times higher disease risk than heterozygotes. Published data indicate that CD8+ T cells may play a major effector role in psoriasis. Epidermal infiltration of predominantly oligoclonal CD8+ T cells, and probably also of CD4+ T cells in the dermis, is a striking feature of chronic psoriasis lesions, indicating that these cells are responding to specific antigens. We argue that CD4+ T cells are essential for initiating and maintaining the pathogenic process of psoriasis but that cross-primed CD8+ T cells are the main effector cells responding to antigens in the HLA-Cw*0602 binding pocket of keratinocytes. It is further proposed that CD8+ T cells are involved in the control of the Th1 polarization, which is observed in psoriasis lesions, through a complex interplay between CD4+, CD8+ T cells and cross-presenting dendritic cells. It is also suggested that spontaneous remissions or fluctuations in disease activity may be determined by a balance within the lesions between effector and suppressor CD4+ and CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678257      PMCID: PMC1808928          DOI: 10.1111/j.1365-2249.2004.02310.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  102 in total

1.  Clinical improvement of HIV-associated psoriasis parallels a reduction of HIV viral load induced by effective antiretroviral therapy.

Authors:  T Fischer; H Schwörer; C Vente; K Reich; G Ramadori
Journal:  AIDS       Date:  1999-04-01       Impact factor: 4.177

2.  Circulating T cells of patients with active psoriasis respond to streptococcal M-peptides sharing sequences with human epidermal keratins.

Authors:  H Sigmundsdottir; B Sigurgeirsson; M Troye-Blomberg; M F Good; H Valdimarsson; I Jonsdottir
Journal:  Scand J Immunol       Date:  1997-06       Impact factor: 3.487

3.  Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.

Authors:  T Wrone-Smith; R S Mitra; C B Thompson; R Jasty; V P Castle; B J Nickoloff
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

4.  Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions.

Authors:  W J Lin; D A Norris; M Achziger; B L Kotzin; B Tomkinson
Journal:  J Invest Dermatol       Date:  2001-12       Impact factor: 8.551

5.  Interleukin 20: discovery, receptor identification, and role in epidermal function.

Authors:  H Blumberg; D Conklin; W F Xu; A Grossmann; T Brender; S Carollo; M Eagan; D Foster; B A Haldeman; A Hammond; H Haugen; L Jelinek; J D Kelly; K Madden; M F Maurer; J Parrish-Novak; D Prunkard; S Sexson; C Sprecher; K Waggie; J West; T E Whitmore; L Yao; M K Kuechle; B A Dale; Y A Chandrasekher
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

6.  Cyclosporin A for psoriasis.

Authors:  W Mueller; B Herrmann
Journal:  N Engl J Med       Date:  1979-09-06       Impact factor: 91.245

7.  Immunocompetent cells in psoriasis. In situ immunophenotyping by monoclonal antibodies.

Authors:  J D Bos; H J Hulsebosch; S R Krieg; P M Bakker; R H Cormane
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

8.  Psoriasis: maintenance of an intact monolayer basal cell differentiation compartment in spite of hyperproliferation.

Authors:  I M Leigh; K A Pulford; F C Ramaekers; E B Lane
Journal:  Br J Dermatol       Date:  1985-07       Impact factor: 9.302

9.  Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

10.  Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells.

Authors:  Joyce T Tan; Bettina Ernst; William C Kieper; Eric LeRoy; Jonathan Sprent; Charles D Surh
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  75 in total

1.  A global gene expression analysis of the peripheral blood mononuclear cells reveals the gene expression signature in psoriasis.

Authors:  Sang-Keun Lee; Eun-Kyoung Jeon; Yu-Jin Kim; Sam-Hwa Seo; Chang-Deok Kim; Jong-Soon Lim; Jeung-Hoon Lee
Journal:  Ann Dermatol       Date:  2009-08-31       Impact factor: 1.444

Review 2.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

3.  Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection.

Authors:  Erik D Cram; Ryan S Simmons; Amy L Palmer; William H Hildebrand; Daniel D Rockey; Brian P Dolan
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

4.  A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.

Authors:  Jian-Jun Chen; Wei Huang; Jin-Ping Gui; Sen Yang; Fu-Sheng Zhou; Quan-Geng Xiong; Hong-Bo Wu; Yong Cui; Min Gao; Wei Li; Jin-Xian Li; Kai-Lin Yan; Wen-Tao Yuan; Shi-Jie Xu; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Am J Hum Genet       Date:  2005-04-04       Impact factor: 11.025

Review 5.  Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution.

Authors:  Annabel Kuek; Brian L Hazleman; Andrew J K Ostör
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

6.  Withasteroid B from D. metel L. regulates immune responses by modulating the JAK/STAT pathway and the IL-17+ RORγt+ /IL-10+ FoxP3+ ratio.

Authors:  Y Su; Q Wang; B Yang; L Wu; G Cheng; H Kuang
Journal:  Clin Exp Immunol       Date:  2017-08-04       Impact factor: 4.330

7.  Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin.

Authors:  Johann E Gudjonsson; Jun Ding; Xing Li; Rajan P Nair; Trilokraj Tejasvi; Zhaohui S Qin; Debashis Ghosh; Abhishek Aphale; Deborah L Gumucio; John J Voorhees; Goncalo R Abecasis; James T Elder
Journal:  J Invest Dermatol       Date:  2009-07-02       Impact factor: 8.551

8.  Treatment Satisfaction, Product Perception, and Quality of Life in Plaque Psoriasis Patients Using Betamethasone Dipropionate Spray 0.05.

Authors:  Joseph F Fowler; James Q Del Rosso; Refika I Pakunlu; Srinivas Sidgiddi
Journal:  J Clin Aesthet Dermatol       Date:  2017-11-01

Review 9.  Psoriasis: a complex clinical and genetic disorder.

Authors:  Helgi Valdimarsson; Ari Karason; Johann E Gudjonsson
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

10.  HLA-Cw*06 class I region rather than MICA is associated with psoriatic arthritis in Czech population.

Authors:  Markéta Fojtíková; Jirí Stolfa; Peter Novota; Pavlína Cejková; Ctibor Dostál; Marie Cerná
Journal:  Rheumatol Int       Date:  2009-01-28       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.